Zuellig Group, one of Asia’s largest healthcare services groups, has acquired Temasek Holdings’ 20 per cent stake in drug distributor Zuellig Pharma. Temasek had reportedly sought $1 billion for its holding in the pharma company last year.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
